Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by Jennifer2020on Aug 30, 2022 4:51am
217 Views
Post# 34928805

Non Disclosure Agreement with GEHC

Non Disclosure Agreement with GEHCIs being used to sandbag performance of VPT.  Friends family and the rest of option and warrant holders get time to load their boats as they use NDA to "hide" sales revenues from inclusion in GEHC's Vivid 4D where VPT'S KBR AI underpins all things echo.
  In my opinion very few people are business and tech savy enough to understand this Unicorn for what it is.  GEHC is scheduled to be spun off parent GE in 2023 so their buyout of VPT might not happen until then.  Until then VPT mgmt is quite happy "pretending" to care about retail investors.
  Why would anyone buy from a Venture Company that may not exist next year when they can buy through GE Health Care, a blue chip company offerring warranty and support?
<< Previous
Bullboard Posts
Next >>